Cutler Group’s VanEck Pharmaceutical ETF PPH Stock Holding History

Cutler Group’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-600	Closed	-$1K	–	4045
2023 Q1	$1K	Buy	+600	New	+$46.3K	﹤0.01%	3522
2022 Q3	–	Sell	-4,400	Closed	-$8K	–	5368
2022 Q2	$8K	Buy	+4,400	New	+$344K	﹤0.01%	3387
2021 Q4	–	Sell	-400	Closed	-$1K	–	5894
2021 Q3	$1K	Buy	+400	New	+$29.8K	﹤0.01%	5384
2021 Q1	–	Sell	-3,500	Closed	-$7K	–	6135
2020 Q4	$7K	Buy	+3,500	New	+$224K	﹤0.01%	3442
2020 Q1	–	Sell	-1,800	Closed	-$5K	–	4498
2019 Q4	$5K	Buy	+1,800	New	+$108K	﹤0.01%	3063

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Cutler Group's PPH Position: Q1 2024 in Review

Cutler Group sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2024, closing a stake of 100 shares — an estimated $8K sold.

Cutler Group first reported a position in PPH in Q1 2016 and held it in 8 quarters. The position peaked at $140K in Q1 2016. 138 funds tracked by Wall St. Rank hold PPH as of Q1 2024.

Cutler Group reported no remaining VanEck Pharmaceutical ETF position as of Q1 2024 after selling out during the quarter.
Cutler Group sold 100 VanEck Pharmaceutical ETF shares in Q1 2024, an estimated $8K.
Cutler Group first reported a position in VanEck Pharmaceutical ETF in Q1 2016 and held it in 8 quarters.
Cutler Group's VanEck Pharmaceutical ETF position peaked at $140K in Q1 2016.
138 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.